An Update on SOC-1882: A Phase 2 Study Using Talimogene Laherparepvec, Nivolumab, and Trabectedin for Advanced Leiomyosarcoma.Sant P. Chawla,Neal Shiv Chawla,Nadezhda Omelchenko,Samantha Jeffrey, Anmol Dia Agarwal,Victoria Chua,Ania Moradkhani,Doris V. Quon,Erlinda Maria GordonJournal of Clinical Oncology（2024）引用 0|浏览10AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
